Dr Stock Pick HOT News & Alerts!

_________________________________________

FREE Daily Stock Alerts From DrStockPick.com

_________________________________________

Monday September 28, 2009

DrStockPick.com Stock Report!

XRX, PWRM, ABT, CSRH, CMCSA, CVAT, FMCN

**************************************************************

XRX, Xerox Corp.

XRX engages in the development, manufacture, marketing, servicing, and financing of document equipment, software, solutions, and services worldwide.

XRX said Monday it will buy Affiliated Computer Services Inc. for $6.4 billion in cash and stock to create a $22 billion business that combines XRX’s copiers, printers and document management services with the “business process outsourcing” of Dallas-based ACS., joining the expensive race among technology companies to broaden their offerings.

**************************************************************

PWRM, Power 3 Medical Products Inc, PWRM.OB

Power3 Medical Products, Inc. is a leading bio-medical company engaged in

Las Vegas - CRWENewswire.com is pleased to announce a stock highlight on Power3 Medical Products, Inc. (OTCBB:PWRM), Xerox Corporation (NYSE: XRX, Cavitation Technologies, Inc. CVAT.OB,

Power3 Medical Products, Inc. (OTCBB:PWRM) (www.power3medical.com), announced today that the Company has filed a patent for Diagnosis of Early Stage Parkinsons Disease: Abnormal: Blood Serum Concentrations of a Select Group of Protein Biomarkers.

Xerox Corporation (NYSE: XRX) digital production color devices account for more than 50 percent of the total worldwide page volume1 – and now print providers have another option for their digital printing needs with the launch of the Xerox DocuColor® 7002/8002 Digital Presses.

Power3 Medical Products, Inc. filed a provisional patent on the diagnosis of early stage Parkinsons disease: abnormal blood serum concentrations of a select group of protein biomarkers. This not only announces to the industry the progress of the Nuro-Pro-PD test for Parkinsons, in validation, utility, but that the importance of the

Las Vegas - CRWENewswire.com is pleased to announce a stock highlight on Power3 Medical Products, Inc. (OTCBB:PWRM), (www.power3medical.com), announced today that the Company has filed a patent for Diagnosis of Early Stage Parkinsons Disease: Abnormal: Blood Serum Concentrations of a Select Group of Protein Biomarkers.

Xerox Corporation (NYSE: XRX) digital production color devices account for more than 50 percent of the total worldwide page volume1 - and now print providers have another option for their digital printing needs with the launch of the Xerox DocuColor® 7002/8002 Digital Presses.

Power3 Medical Products, Inc. filed a provisional patent on the diagnosis of early stage Parkinsons disease: abnormal blood serum concentrations of a select group of protein biomarkers. This not only announces to the industry the progress of the Nuro-Pro-PD test for Parkinsons, in validation, utility, but that the importance of the Power3 protein biomarkers are statistically valid for use as a diagnostic test.